FHLC vs. TMO

Last updated Jun 13, 2026

FHLC (Fidelity MSCI Health Care Index ETF) is Health & Biotech Equities fund tracking the MSCI USA IMI Health Care Index, while TMO (Thermo Fisher Scientific Inc.) is a stock. Over the past 10 years, FHLC returned 9.76%/yr vs 12.54%/yr for TMO. A 0.69 correlation means they provide meaningful diversification when combined.

Performance

FHLC vs. TMO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Fidelity MSCI Health Care Index ETF (FHLC) and Thermo Fisher Scientific Inc. (TMO). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, FHLC achieves a 0.03% return, which is significantly higher than TMO's -18.92% return. Over the past 10 years, FHLC has underperformed TMO with an annualized return of 9.76%, while TMO has yielded a comparatively higher 12.54% annualized return.

FHLC

• 1D: -0.13%
• 1M: 4.40%
• YTD: 0.03%
• 6M: 0.58%
• 1Y: 15.99%
• 3Y*: 7.18%
• 5Y*: 4.76%
• 10Y*: 9.76%

TMO

• 1D: -1.33%
• 1M: 5.23%
• YTD: -18.92%
• 6M: -17.84%
• 1Y: 13.42%
• 3Y*: -3.43%
• 5Y*: 0.45%
• 10Y*: 12.54%

*Multi-year figures are annualized to reflect compound growth (CAGR)

FHLC vs. TMO - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
FHLC Fidelity MSCI Health Care Index ETF	0.03%	15.42%	2.48%	2.58%	-5.55%	20.39%	18.13%	21.94%	4.71%	23.34%
TMO Thermo Fisher Scientific Inc.	-18.92%	11.78%	-1.72%	-3.36%	-17.29%	43.54%	43.72%	45.55%	18.21%	35.03%

Correlation

The correlation between FHLC and TMO is 0.54, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.54
Correlation (3Y) Calculated over the trailing 3-year period	0.60
Correlation (5Y) Calculated over the trailing 5-year period	0.65
Correlation (10Y) Calculated over the trailing 10-year period	0.68
Correlation (All Time) Calculated using the full available price history since Oct 24, 2013	0.69

The correlation between FHLC and TMO shifts across timeframes, from 0.54 (1 year) to 0.69 (all time), reflecting how their relationship changes across market environments.

Return for Risk

FHLC vs. TMO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FHLC

FHLC Risk / Return Rank: 34
FHLC Sharpe Ratio Rank: 34
FHLC Sortino Ratio Rank: 37
FHLC Omega Ratio Rank: 32
FHLC Calmar Ratio Rank: 35
FHLC Martin Ratio Rank: 30

TMO

TMO Risk / Return Rank: 54
TMO Sharpe Ratio Rank: 58
TMO Sortino Ratio Rank: 53
TMO Omega Ratio Rank: 51
TMO Calmar Ratio Rank: 53
TMO Martin Ratio Rank: 53

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

FHLC vs. TMO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Fidelity MSCI Health Care Index ETF (FHLC) and Thermo Fisher Scientific Inc. (TMO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	FHLC	TMO	Difference
Sharpe ratio: Return per unit of total volatility	1.09	0.43	+0.67
Sortino ratio: Return per unit of downside risk	1.72	0.87	+0.85
Omega ratio: Gain probability vs. loss probability	1.19	1.10	+0.09
Calmar ratio: Return relative to maximum drawdown	1.55	0.43	+1.12
Martin ratio: Return relative to average drawdown	3.86	0.93	+2.93

FHLC vs. TMO - Sharpe Ratio Comparison

The current FHLC Sharpe Ratio is 1.09, which is higher than the TMO Sharpe Ratio of 0.43. The chart below compares the historical Sharpe Ratios of FHLC and TMO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

FHLC vs. TMO - Drawdown Comparison

The maximum FHLC drawdown since its inception was -28.76%, smaller than the maximum TMO drawdown of -71.16%. Use the drawdown chart below to compare losses from any high point for FHLC and TMO.

Drawdown Indicators

	FHLC	TMO	Difference
Max Drawdown Largest peak-to-trough decline	-28.76%	-71.16%	+42.40%
Max Drawdown (1Y) Largest decline over 1 year	-10.38%	-31.38%	+21.00%
Max Drawdown (3Y) Largest decline over 3 years	-16.87%	-37.28%	+20.41%
Max Drawdown (5Y) Largest decline over 5 years	-17.73%	-40.95%	+23.22%
Max Drawdown (10Y) Largest decline over 10 years	-28.76%	-40.95%	+12.19%
Current Drawdown Current decline from peak	-3.15%	-28.80%	+25.65%
Average Drawdown Average peak-to-trough decline	-5.19%	-18.11%	+12.92%
Ulcer Index Depth and duration of drawdowns from previous peaks	4.16%	14.43%	-10.27%

Volatility

FHLC vs. TMO - Volatility Comparison

The current volatility for Fidelity MSCI Health Care Index ETF (FHLC) is 4.87%, while Thermo Fisher Scientific Inc. (TMO) has a volatility of 10.57%. This indicates that FHLC experiences smaller price fluctuations and is considered to be less risky than TMO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	FHLC	TMO	Difference
Volatility (1M) Calculated over the trailing 1-month period	4.87%	10.57%	-5.70%
Volatility (6M) Calculated over the trailing 6-month period	10.50%	22.27%	-11.77%
Volatility (1Y) Calculated over the trailing 1-year period	14.69%	31.48%	-16.79%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	15.02%	27.20%	-12.18%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	16.84%	26.38%	-9.54%

Dividends

FHLC vs. TMO - Dividend Comparison

FHLC's dividend yield for the trailing twelve months is around 1.37%, more than TMO's 0.37% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
FHLC Fidelity MSCI Health Care Index ETF	1.37%	1.40%	1.51%	1.40%	1.30%	1.16%	1.45%	1.18%	1.38%	1.38%	1.40%	2.07%
TMO Thermo Fisher Scientific Inc.	0.37%	0.30%	0.30%	0.26%	0.22%	0.16%	0.19%	0.23%	0.30%	0.32%	0.43%	0.42%

Frequently Asked Questions

Can I hold both FHLC and TMO in my portfolio?

FHLC and TMO have a correlation of 0.54, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, FHLC or TMO?

TMO has higher volatility (10.57%) compared to FHLC (4.87%). In terms of maximum drawdown, FHLC dropped -28.76% vs TMO's -71.16%.

Which has better risk-adjusted returns?

FHLC currently has the higher Sharpe Ratio (1.09 vs 0.43), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.